| Gene symbol | CD276 | Synonyms | 4Ig-B7-H3, B7-H3, B7H3, B7RP-2 | Type of gene | protein-coding |
| Chromosome | 15 | Map location | 15q24.1 | dbXrefs | |
| Description | CD276 molecule | ||||
| GTO ID | GTC0894 |
| Trial ID | ChiCTR2000040261 |
| Disease | Abdominal Metastatic Malignant Tumor |
| Altered gene | CD276 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | TX103 CAR-T cells |
| Phase | Early_Phase1 |
| Recruitment status | Recruiting |
| Title | Clinical trial of TX103-CAR-T cells in the treatment of abdominal metastatic malignant tumor |
| Year | 2020 |
| Country | China |
| Company sponsor | Fujian Medical University Union Hospital |
| Cohort1: incremental dose | |||||||||
|
|||||||||
| Cohort2: decremental dose | |||||||||
|
|||||||||